Browsing Tag
BioStem Technologies
2 posts
BioStem Technologies (OTC: BSEM) acquires BioTissue wound care unit to expand hospital market presence
BioStem acquires BioTissue’s wound care business for $15M, gaining GPO access, sales force, and acute care exposure. Find out what this means for growth.
January 23, 2026
BioStem Technologies unveils top-line data proving BioRetain allograft’s superior healing benefits in diabetic foot ulcers
Find out how BioStem Technologies’ BioRetain allograft is improving diabetic foot ulcer healing outcomes and shaping regenerative wound care.
October 31, 2025